BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20132211)

  • 1. KMUP-1 attenuates isoprenaline-induced cardiac hypertrophy in rats through NO/cGMP/PKG and ERK1/2/calcineurin A pathways.
    Yeh JL; Hsu JH; Wu PJ; Liou SF; Liu CP; Chen IJ; Wu BN; Dai ZK; Wu JR
    Br J Pharmacol; 2010 Mar; 159(5):1151-60. PubMed ID: 20132211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KMUP-1 inhibits hypertension-induced left ventricular hypertrophy through regulation of nitric oxide synthases, ERK1/2, and calcineurin.
    Yeh JL; Liu CP; Hsu JH; Tseng CJ; Wu PJ; Wang YY; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2012 Nov; 28(11):567-76. PubMed ID: 23140764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KMUP-1 regulates the vascular calcification in chronic renal failure by mediating NO/cGMP/PKG signaling pathway.
    Ren LS; Zhang L; Zhu D; Li T; Wang Q; Yuan XY; Hao LR
    Life Sci; 2020 Jul; 253():117683. PubMed ID: 32315727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.
    Liou SF; Hsu JH; Chen YT; Chen IJ; Yeh JL
    Molecules; 2015 Jun; 20(6):10435-49. PubMed ID: 26056815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KMUP-1 Ameliorates Ischemia-Induced Cardiomyocyte Apoptosis through the NO⁻cGMP⁻MAPK Signaling Pathways.
    Lee ML; Sulistyowati E; Hsu JH; Huang BY; Dai ZK; Wu BN; Chao YY; Yeh JL
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30965668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of proinflammatory tumor necrosis factor-{alpha}-induced inducible nitric-oxide synthase by xanthine-based 7-[2-[4-(2-chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in rat trachea: The involvement of soluble guanylate cyclase and protein kinase G.
    Wu BN; Chen CW; Liou SF; Yeh JL; Chung HH; Chen IJ
    Mol Pharmacol; 2006 Sep; 70(3):977-85. PubMed ID: 16754782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
    Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
    Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A xanthine-based epithelium-dependent airway relaxant KMUP-3 (7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine) increases respiratory performance and protects against tumor necrosis factor-alpha-induced tracheal contraction, involving nitric oxide release and expression of cGMP and protein kinase G.
    Lin RJ; Wu BN; Lo YC; An LM; Dai ZK; Lin YT; Tang CS; Chen IJ
    J Pharmacol Exp Ther; 2006 Feb; 316(2):709-17. PubMed ID: 16234412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KMUP-1 attenuates serum deprivation-induced neurotoxicity in SH-SY5Y cells: roles of PKG, PI3K/Akt and Bcl-2/Bax pathways.
    Hsu YY; Liu CM; Tsai HH; Jong YJ; Chen IJ; Lo YC
    Toxicology; 2010 Jan; 268(1-2):46-54. PubMed ID: 19962417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A xanthine-based KMUP-1 with cyclic GMP enhancing and K(+) channels opening activities in rat aortic smooth muscle.
    Wu BN; Lin RJ; Lin CY; Shen KP; Chiang LC; Chen IJ
    Br J Pharmacol; 2001 Sep; 134(2):265-74. PubMed ID: 11564644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KMUP-1, a xanthine derivative, induces relaxation of guinea-pig isolated trachea: the role of the epithelium, cyclic nucleotides and K+ channels.
    Wu BN; Lin RJ; Lo YC; Shen KP; Wang CC; Lin YT; Chen IJ
    Br J Pharmacol; 2004 Aug; 142(7):1105-14. PubMed ID: 15237094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cGMP-enhancing- and alpha1A/alpha1D-adrenoceptor blockade-derived inhibition of Rho-kinase by KMUP-1 provides optimal prostate relaxation and epithelial cell anti-proliferation efficacy.
    Liu CM; Lo YC; Wu BN; Wu WJ; Chou YH; Huang CH; An LM; Chen IJ
    Prostate; 2007 Sep; 67(13):1397-410. PubMed ID: 17639498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic guanosine monophosphate-enhancing reduces androgenic extracellular regulated protein kinases-phosphorylation/Rho kinase II-activation in benign prostate hyperplasia.
    Liu CM; Fan YC; Lo YC; Wu BN; Yeh JL; Chen IJ
    Int J Urol; 2014 Jan; 21(1):87-92. PubMed ID: 23692571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
    Bouallegue A; Daou GB; Srivastava AK
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molsidomine Attenuates Ventricular Electrical Remodeling and Arrhythmogenesis in Rats With Chronic β-Adrenergic Receptor Activation Through the NO/cGMP/PKG Pathway.
    Shan Y; Wang D; Li R; Huang C
    J Cardiovasc Pharmacol; 2016 Nov; 68(5):342-355. PubMed ID: 27482866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase inhibitor KMUP-3 displays cardioprotection via protein kinase G and increases cardiac output via G-protein-coupled receptor agonist activity and Ca(2+) sensitization.
    Liu CP; Yeh JL; Liou SF; Wu BN; Chen IJ
    Kaohsiung J Med Sci; 2016 Feb; 32(2):55-67. PubMed ID: 26944323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthine-based KMUP-1 improves HDL via PPARγ/SR-B1, LDL via LDLRs, and HSL via PKA/PKG for hepatic fat loss.
    Kuo KK; Wu BN; Liu CP; Yang TY; Kao LP; Wu JR; Lai WT; Chen IJ
    J Lipid Res; 2015 Nov; 56(11):2070-84. PubMed ID: 26351364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.